Leonard C. Glass

Leonard C. Glass is the Senior Vice President of Global Medical Affairs at Eli Lilly, where he plays a crucial role in overseeing the medical strategies for the company's cardiometabolic health products. In the context of recent clinical studies, Glass highlighted the significance of the findings regarding the efficacy of tirzepatida (Mounjaro) compared to semaglutida (Ozempic and Wegovy) in treating obesity, emphasizing the importance of informed decision-making for healthcare professionals and patients.